|
Volumn 16, Issue 1, 2003, Pages 139-143
|
Cholesterol crystal embolic disease in renal allografts.
a a a a a a a a a
a
SPEDALI CIVILI
(Italy)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ALLOTRANSPLANTATION;
CHRONIC DISEASE;
CHRONIC KIDNEY FAILURE;
DONOR;
FAT EMBOLISM;
FEMALE;
FOLLOW UP;
GRAFT REJECTION;
HOSPITALIZATION;
HUMAN;
KIDNEY FUNCTION TEST;
KIDNEY TRANSPLANTATION;
MALE;
METHODOLOGY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
NEEDLE BIOPSY;
PATHOLOGY;
RENAL REPLACEMENT THERAPY;
REVIEW;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ANTICOAGULANTS;
BIOPSY, NEEDLE;
CHRONIC DISEASE;
COMBINED MODALITY THERAPY;
EMBOLISM, CHOLESTEROL;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMANS;
KIDNEY FAILURE, CHRONIC;
KIDNEY FUNCTION TESTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
RENAL DIALYSIS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TISSUE DONORS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 0038159969
PISSN: 11218428
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (15)
|
References (12)
|